Literature DB >> 29845216

TROP2 promotes cell proliferation and migration in osteosarcoma through PI3K/AKT signaling.

Qing-Zhi Gu1, Abulimiti Nijiati1, Xing Gao1, Kai-Liang Tao1, Cheng-Duo Li1, Xue-Peng Fan1, Zheng Tian1.   

Abstract

Human trophoblast cell surface antigen 2 (TROP2) has been noted to serve an important role in the proliferation and migration of various types of human cancers. However, the potential role and the molecular mechanisms of TROP2 in osteosarcoma (OS) remain largely unclear. In the present study, high expression of TROP2 in human OS tissues and cell lines was observed. Overexpression of TROP2 promoted the proliferation and migration of OS cell lines, while TROP2 knockdown markedly decreased cell growth and migration. Furthermore, it was revealed that TROP2 overexpression significantly activated the phosphoinositide 3‑kinase/protein kinase B (PI3K/AKT) signaling pathway. Collectively, these results suggested that TROP2 may promote OS cell proliferation and migration via PI3K/AKT signaling and may serve as a novel treatment target for OS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29845216     DOI: 10.3892/mmr.2018.9083

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

1.  Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer.

Authors:  Christina Yau; Hope Rugo; Neelima Vidula
Journal:  Breast Cancer Res Treat       Date:  2022-07-04       Impact factor: 4.624

2.  Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments.

Authors:  Shota Omori; Koji Muramatsu; Takuya Kawata; Eriko Miyawaki; Taichi Miyawaki; Nobuaki Mamesaya; Takahisa Kawamura; Haruki Kobayashi; Kazuhisa Nakashima; Kazushige Wakuda; Akira Ono; Hirotsugu Kenmotsu; Tateaki Naito; Haruyasu Murakami; Takashi Sugino; Toshiaki Takahashi
Journal:  J Cancer Res Clin Oncol       Date:  2021-09-17       Impact factor: 4.322

3.  The Role of TROP2 in BCC and Cutaneous SCC: A Clinical and Immunohistochemical Study.

Authors:  Azza Gaber Antar Farag; Hala Said El-Rebey; Mohamed Abd El-Moneim Shoeib; Shimaa Mohammed Ahmed El-Fiky; Mustafa Elsayed Elshaib; Amal Farid Mostafa
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-06-01

4.  Peroxiredoxin 1 silencing inhibited the growth and promoted apoptosis of pancreatic cancer cells via targeting FOXO3 gene.

Authors:  Xianchun Sun; Lingting Kong; Bingshu Li; Yan Zhang; Haiyan Yang
Journal:  Cancer Manag Res       Date:  2018-10-26       Impact factor: 3.989

5.  Silencing of the TROP2 gene suppresses proliferation and invasion of hepatocellular carcinoma HepG2 cells.

Authors:  Jian Zhang; Hai Ma; Liu Yang; Hongchun Yang; Zhenxing He
Journal:  J Int Med Res       Date:  2019-01-24       Impact factor: 1.671

6.  TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway.

Authors:  Genxiong Tang; Qi Tang; Lizhou Jia; Yuan Chen; Liangyuan Lin; Xingwang Kuai; Aixiu Gong; Zhengqing Feng
Journal:  Int J Mol Med       Date:  2019-10-21       Impact factor: 4.101

7.  Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway.

Authors:  Xin Zhao; Yuying Fang; Xingwen Wang; Zhouyuan Yang; Donghai Li; Meng Tian; Pengde Kang
Journal:  Int J Oncol       Date:  2019-11-14       Impact factor: 5.650

Review 8.  Trop2: Jack of All Trades, Master of None.

Authors:  Sára Lenárt; Peter Lenárt; Jan Šmarda; Ján Remšík; Karel Souček; Petr Beneš
Journal:  Cancers (Basel)       Date:  2020-11-11       Impact factor: 6.639

9.  CORO1C is Associated With Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer.

Authors:  Zongxia Wang; Lizhou Jia; Yushu Sun; Chunli Li; Lingli Zhang; Xiangcheng Wang; Hao Chen
Journal:  Front Mol Biosci       Date:  2021-06-10

10.  Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.

Authors:  Baoping Zhang; Shuting Gao; Ruiping Li; Yiting Li; Rui Cao; Jingyang Cheng; Yumeng Guo; Errui Wang; Ying Huang; Kailiang Zhang
Journal:  BMC Cancer       Date:  2020-08-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.